On March 2nd and 9th IDIBAPS participated in Escolab 2016, an initiative of the Barcelona City Council that encourages students in secondary educati1
An international study shows the efficacy of a monoclonal antibody, Dupilumab, to treat chronic rhinosinusitis with nasal polyposis, when the standa1
The technologies presented at the Graphene Pavilion of the Mobile World Congress take show different applications of graphene, form batteries to fle1
Dr. Pere Santamaria, researcher at the University of Calgary and IDIBAPS, coordinates a study published in Nature that provides a new approach to un1
Following the success of the first edition of the PhD programme for physicians - PhD4MD, an initiative created by the Centre for Genomic Regulation1
Dr. Jaime de la Rocha, head of Cortical Circuit Dynamics research group at IDIBAPS, will receive €2 million over the next five years to strengthen hi1
IDIBAPS takes part in the European HIV Vaccine Alliance (EHVA) to develop and evaluate new preventive and therapeutic vaccines. The European Commiss1
Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with Institute of1
IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commissio1
